Although we did not have single cell level data to show subsets of TAMs in cervical cancer, we showed that, by using bulk RNA-seq data of cervical cancer from TCGA, C1QC+ and SPP1+ TAMs gene signatures, but not M1 and M2 gene signatures, could divide cervical cancer patients into subgroups with different prognosis and different tumor stages. This evidence concerns the gene SPP1 and cervical carcinoma.